Update: Silva Pharmaceuticals Limited subscription will start from 29 August’18 to 5 August’18
The Bangladesh Securities Exchange Commission (BSEC) approved IPO Silva Pharmaceuticals Limited on Monday, 11 June 2018 at their 647 nos Board Meeting. Presided over by BSEC Chairman Prof. Dr. M Khairul Hossain to issue 3.00 crore ordinary shares worth Tk 10 each. Company Information, IPO Application Form, Prospectus & Result is given below:
Company Name: Silva Pharmaceuticals Limited. (Hereinafter referred to as “SPL”)
Incorporation: The Company was incorporated on 24 April 2001 as a private limited Company and was subsequently converted into a public limited company on 24 April 2014.
Commercial Operation: Silva Pharmaceuticals Limited was started commercial operation on 1 July 2003.
Authorized Capital: Tk. 1,500,000,000 divided into 150,000,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (Before IPO): Tk. 1,000,000,000 divided into 100,000,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (After IPO): Tk. 1,300,000,000 divided into 130,000,000 ordinary shares of Tk. 10.00 each
Management Body: 1) Mrs. Silvana Mirza, Chairman
2) Dr. Saira Khan, Managing Director & Director
3) Mrs. Samina Mirza, Director
4) Mrs. Farhana Mirza, Director
5) Md. Nazrul Islam Khan, Nominated by Investment Corporation of Bangladesh (ICB)
6) Mr. Monsur Rahman, Nominated by Adarsha Fisheries & Poultry Farm Ltd.
7) Md. Musfiqur Rahman FCA, Independent Director
8) Tanha Zarrin Ahmed , Independent Director
ABOUT THE ISSUER:
The Company has following products: Details Products List
NAME OF SUBSIDIARIES:
There is no subsidiaries company of Silva Pharmaceuticals Limited.
Registered & Corporate Office :
Phone: +88-02-8129915, +88-02-9146009
MAJOR FINANCIAL INFORMATION AS FOLLOWS:
Figure in Tk.’000
|Particulars||30-06-17 (12 Months)
||30-06-16 (13 Months)
|Net Profit before tax||123,763||114,961||79,935||78,914||71,794|
|Net Profit after tax||80,279||74,725||51,958||49,321||44,871|
|No. of Shares||100,000||50,000||12,000||12,000||12,000|
|NAV per Shares||16.48||21.71||52.55||49.65||48.47|
|Earnings per Share||1.03||1.24||1.06||1.00||0.91|
SILVA PHARMACEUTICALS LIMITED EPS & NAV:
As per the financial statement for the year ended on June 30, 2017, the company’s net asset value (NAV) without revaluation stood at Tk 16.48 per share and weighted average of EPS was Tk 1.03
Prime Finance Capital Management, Imperial Capital Limited and SBL Capital Management Limited are jointly working as the manager of the issue.
WHY PUBLIC OFFERING:
Bangladesh Securities Exchange Commission (BSEC) approved IPO of above Co. on 11 June 2018. The companies will raise a fund worth Tk. 300.00 million.
NOS. OF SHARE OFFER: 3,00,00,000
VALUE OF IPO: Tk. 300,000,000/=
FACE VALUE: Tk. 10/=
PREMIUM VALUE: Nil
MARKET LOT: 500
MINIMUM LOT VALUE: Tk.5000/=
SHARE ALLOTMENT: 32% for General Public=19,200 lot and 8% for Affected Investors=4,800 lot, 40% for Eligible Investor (EI) =24,000 lot, 10% for NRB = 6,000 lot and 10% for Mutual Fund =6,000 lot.
** The Company will collect IPO money through BSEC new rules and the new rule is “BROKER HOUSE SHOULD COLLECT IPO MONEY ONLY”.
The Company’s Subscription will start from 29 July 18 to 5 August 18.
DOWNLOAD IPO FORM HERE:
Silva Pharmaceuticals Limited: PROSPECTUS
DOWNLOAD LOTTERY RESULT HERE:
YET TO BE PUBLISHED
Stock Broker / Merchant Bank Code
Non-Residence Bangladeshi (NRB)
THANK YOU FOR VISITING HITBANGLA.COM
Incoming search terms:
silva pharmaceuticals ltd ipo information, www Silvapharmaceuticals ipo information, ziaul roshan rikto